Signaturefd LLC Raises Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Signaturefd LLC grew its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 13.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,492 shares of the medical research company’s stock after buying an additional 287 shares during the quarter. Signaturefd LLC’s holdings in IQVIA were worth $577,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. AdvisorNet Financial Inc lifted its holdings in IQVIA by 327.6% during the 4th quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock worth $29,000 after buying an additional 95 shares during the last quarter. BKM Wealth Management LLC acquired a new stake in shares of IQVIA during the 4th quarter worth approximately $32,000. Activest Wealth Management acquired a new stake in shares of IQVIA during the 4th quarter worth approximately $35,000. CVA Family Office LLC acquired a new stake in shares of IQVIA during the 4th quarter worth approximately $43,000. Finally, CoreFirst Bank & Trust acquired a new stake in shares of IQVIA during the 3rd quarter worth approximately $44,000. Institutional investors own 89.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on IQV. SVB Leerink began coverage on IQVIA in a research report on Monday, February 26th. They set an “outperform” rating and a $290.00 price target on the stock. Evercore ISI increased their price target on IQVIA from $255.00 to $265.00 and gave the stock a “market outperform” rating in a research report on Thursday, February 15th. Truist Financial increased their price target on IQVIA from $286.00 to $297.00 and gave the stock a “buy” rating in a research report on Tuesday, February 27th. Guggenheim cut IQVIA from a “buy” rating to a “neutral” rating in a research report on Thursday, February 15th. Finally, Barclays raised their target price on IQVIA from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $256.80.

Insider Transactions at IQVIA

In other news, insider Ari Bousbib sold 31,678 shares of the firm’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $250.53, for a total value of $7,936,289.34. Following the completion of the sale, the insider now owns 796,752 shares of the company’s stock, valued at $199,610,278.56. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, insider Eric Sherbet sold 1,000 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $241.50, for a total value of $241,500.00. Following the completion of the sale, the insider now owns 20,836 shares of the company’s stock, valued at $5,031,894. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Ari Bousbib sold 31,678 shares of the firm’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $250.53, for a total value of $7,936,289.34. Following the completion of the sale, the insider now directly owns 796,752 shares of the company’s stock, valued at approximately $199,610,278.56. The disclosure for this sale can be found here. Insiders sold a total of 41,285 shares of company stock valued at $10,331,003 in the last three months. 1.60% of the stock is currently owned by corporate insiders.

IQVIA Stock Performance

IQV opened at $240.84 on Thursday. The firm has a market cap of $43.71 billion, a PE ratio of 33.04, a P/E/G ratio of 2.31 and a beta of 1.50. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 2.12. The business has a fifty day simple moving average of $245.50 and a 200-day simple moving average of $222.69. IQVIA Holdings Inc. has a fifty-two week low of $167.42 and a fifty-two week high of $261.73.

IQVIA (NYSE:IQV) last released its quarterly earnings data on Wednesday, February 14th. The medical research company reported $2.84 earnings per share for the quarter, topping the consensus estimate of $2.82 by $0.02. The business had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.80 billion. IQVIA had a return on equity of 29.32% and a net margin of 9.06%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same period last year, the company posted $2.54 EPS. As a group, equities analysts predict that IQVIA Holdings Inc. will post 10.11 EPS for the current fiscal year.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.